SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-025483
Filing Date
2023-09-08
Accepted
2023-09-08 15:42:44
Documents
1
Period of Report
2023-09-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3531
  Complete submission text file 0001437749-23-025483.txt   4828
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 12520 SUNNYDALE DRIVE WELLINGTON FL 33414
Business Address
Wildman Daniel George (Reporting) CIK: 0001952679 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 231245173